A prospective study of 95,612 U.S. adults found that those with the highest sulfur microbial diet scores had a 23% higher ...

A hockey broadcaster reveals she underwent surgery after a spot on her nose that she thought was a pimple turned out to be ...

BioNTech's BNT113 misses Phase III PFS endpoint in HPV16-positive head and neck cancer. Read the full trial update and what ...

One of BioNTech's prospective cancer vaccines has failed to show benefit in one of its dual primary endpoints in a Phase ...

Head and neck squamous cell carcinoma (HNSCC) frequently develops in the oral and upper aerodigestive regions following ...

While BNT113 failed to improve progression-free survival in patients with a type of head and neck cancer during a Phase 3 ...

BioNTech Shares Update on Phase 2/3 Clinical Trial for mRNA Cancer Immunotherapy in Metastatic HPV16-Positive HNC / ...

HPV16-positive HNSCC represents a subset of head and neck cancers, and treatment options remain limited for patients with recurrent or metastatic disease. BNT113 received Fast Track Designation from ...

An early data check showed the shot didn’t delay tumor progression in a form of head and neck cancer, though BioNTech is ...

BioNTech said on Tuesday its experimental mRNA cancer immunotherapy failed to meet the first main ​goal of a ...

AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy ...

Michelle Emerson, a stage three head and neck cancer survivor, created a nonprofit to help patients manage painful symptoms.